This is a festive break from my usual offerings on emergency toxicology, although you will note I lapsed a bit with dextromethorphan. My last post was on the SNAP regimen […]
Cough remedies: what actually works? Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
High dose vs. Low dose steroids in hospitalised COVID 19 patients. St Emlyn’s. Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More
Natalie May reviews day 1 of the #ICEM22 conference in Melbourne, Australia @stemlyns @_nmay #FOAMed @icem2022 @ifempreselect @ifem2
#ICEM22 Melbourne – Day 1 Read More
Editor: This is a guest post by Simon Horne. It is likely one of the last posts from Virchester before the festive season properly commences. Take care and stay safe.
Thinking pragmatically about capacity Read More
I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic
JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s Read More
Co-authored with Dan Darbyshire (@dsdarbyshire) Training and practicing in emergency medicine has been hard the last 18 months. The 2020 EMTA survey tells us where things are not working and
EMTA Survey 2020: The good, the bad and the ugly Read More
Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More
